Venetoclax with high ‐dose methotrexate and rituximab seem effective and well‐tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report

Venetoclax with high ‐dose methotrexate and rituximab seem effective and safe to treat central nervous system involvement of chronic lymphocytic leukemia. AbstractVenetoclax with high ‐dose methotrexate and rituximab seem effective and safe to treat central nervous system involvement of chronic lymphocytic leukemia.

Source: Clinical Case Reports - January 9, 2020 Category: General Medicine Authors: Guillaume Beziat, Martin Gauthier, Caroline Protin, Lucie Oberic, Fleur Lerebours, Jasmine Carlier, Lo ïc Ysebaert Tags: CASE REPORT Source Type: research